DNAM-1 Expression Marks an Alternative Program of NK Cell Maturation
Ludovic Martinet(Centre National de la Recherche Scientifique), Mark J. Smyth(Peter MacCallum Cancer Centre)
Cited by 125
Related Papers
Immune surveillance of tumors
|Journal of Clinical Investigation|2007|1.4k
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
|Annals of Oncology|2014|1.3k
Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells
|Nature Immunology|2017|639